146 related articles for article (PubMed ID: 33768191)
1. Brodifacoum pharmacokinetics in acute human poisoning: implications for estimating duration of vitamin K therapy.
Nosal DG; van Breemen RB; Haffner JW; Rubinstein I; Feinstein DL
Toxicol Commun; 2021; 5(1):69-72. PubMed ID: 33768191
[TBL] [Abstract][Full Text] [Related]
2. Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids.
Feinstein DL; Nosal DG; Ramanathan S; Zhou J; Chen L; Hershow RC; van Breemen RB; Wright E; Hafner JW; Rubinstein I
Clin Toxicol (Phila); 2020 Jul; 58(7):716-724. PubMed ID: 31736367
[No Abstract] [Full Text] [Related]
3. Treatment for long acting anticoagulant rodenticide poisoning - beyond INR monitoring?
Rubinstein I; Weinberg G; van Breemen R; Hershow RC; Feinstein DL
Toxicol Commun; 2018; 2(1):59-61. PubMed ID: 30923779
[TBL] [Abstract][Full Text] [Related]
4. The Bile Sequestrant Cholestyramine Increases Survival in a Rabbit Model of Brodifacoum Poisoning.
Lindeblad M; Lyubimov A; van Breemen R; Gierszal K; Weinberg G; Rubinstein I; Feinstein DL
Toxicol Sci; 2018 Oct; 165(2):389-395. PubMed ID: 29897553
[TBL] [Abstract][Full Text] [Related]
5. Adherence to Long-Term Follow-Up of Patients with Life-Threatening, Inhaled Synthetic Cannabinoids-Associated Coagulopathy in Chicago.
Tole M; LaBedz S; Feinstein DL; Rubinstein I
Lung; 2019 Jun; 197(3):349-352. PubMed ID: 31004190
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of clinical characteristics of and treatment strategies for patients with long-acting anticoagulant rodenticide poisoning.
Guodong L; Jieyi W; Xiaobo P; Xiaoxia L; Zhongying L; Zhiguo P; Zewu Q; Jianguang D
Basic Clin Pharmacol Toxicol; 2022 Jul; 131(1):74-82. PubMed ID: 35470573
[TBL] [Abstract][Full Text] [Related]
7. Unmet clinical laboratory need in patients hospitalized for acute poisoning from long-acting anticoagulant rodenticides.
van Breemen RB; Hafner JW; Nosal DG; Feinstein DL; Rubinstein I
Toxicol Commun; 2021; 5(1):93-96. PubMed ID: 34458660
[TBL] [Abstract][Full Text] [Related]
8. Short-term treatment with cholestyramine increases long-acting anticoagulant rodenticide clearance from rabbits without affecting plasma vitamin K1 levels or blood coagulation.
Muchiri RN; Rocha J; Tandon A; Chen YL; Alemani R; Ahmad I; McDonald Z; Lindeblad M; Rubinstein I; van Breemen RB; Feinstein DL
Toxicol Sci; 2024 Jun; 200(1):137-145. PubMed ID: 38603617
[TBL] [Abstract][Full Text] [Related]
9. Long-Acting Anticoagulant Rodenticide (Superwarfarin) Poisoning: A Review of Its Historical Development, Epidemiology, and Clinical Management.
King N; Tran MH
Transfus Med Rev; 2015 Oct; 29(4):250-8. PubMed ID: 26239439
[TBL] [Abstract][Full Text] [Related]
10. Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?
Rubinstein I; van Breemen R; Nosal DG; Weinberg G; Hershow RC; Feinstein DL
Drugs R D; 2019 Mar; 19(1):67-71. PubMed ID: 30689138
[TBL] [Abstract][Full Text] [Related]
11. Sugar, Spice, and Bleeding.
Shahid Z; Kalayanamitra R; Hanafi M; Anwar K; Jain R
Cureus; 2019 Apr; 11(4):e4437. PubMed ID: 31245224
[TBL] [Abstract][Full Text] [Related]
12. Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing.
Bruno GR; Howland MA; McMeeking A; Hoffman RS
Ann Emerg Med; 2000 Sep; 36(3):262-7. PubMed ID: 10969235
[TBL] [Abstract][Full Text] [Related]
13. An outbreak of severe coagulopathy from synthetic cannabinoids tainted with Long-Acting anticoagulant rodenticides.
Devgun JM; Rasin A; Kim T; Mycyk MB; Bryant SM; Wahl MS; DesLauriers C; Navon L; Moritz ED; Thompson TM; Swoboda HD; Lu J; Aks SE
Clin Toxicol (Phila); 2020 Aug; 58(8):821-828. PubMed ID: 31797705
[No Abstract] [Full Text] [Related]
14. Oral administration of injectable vitamin K1 in brodifacoum intoxication.
Chu YJ; Lin JH; Hung DZ
Biomedicine (Taipei); 2022; 12(2):47-49. PubMed ID: 35836972
[TBL] [Abstract][Full Text] [Related]
15. Coagulopathic effects and therapy of brodifacoum toxicosis in dogs.
Woody BJ; Murphy MJ; Ray AC; Green RA
J Vet Intern Med; 1992; 6(1):23-8. PubMed ID: 1548622
[TBL] [Abstract][Full Text] [Related]
16. Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides: Observational case series and management recommendations.
Bahouth MN; Kraus P; Dane K; Plazas Montana M; Tsao W; Tabaac B; Jasem J; Schmidlin H; Einstein E; Streiff MB; Shanbhag S
Medicine (Baltimore); 2019 Sep; 98(36):e17015. PubMed ID: 31490385
[TBL] [Abstract][Full Text] [Related]
17. Persistent Coagulopathy After Synthetic Cannabinoid Use.
Haider M; Acevedo-Cajigas C; Ortiz D; Zorrilla CA; Perez J
Cureus; 2023 Mar; 15(3):e36156. PubMed ID: 37065401
[TBL] [Abstract][Full Text] [Related]
18. Surreptitious ingestion of a long-acting vitamin K antagonist/rodenticide, brodifacoum: clinical and metabolic studies of three cases.
Weitzel JN; Sadowski JA; Furie BC; Moroose R; Kim H; Mount ME; Murphy MJ; Furie B
Blood; 1990 Dec; 76(12):2555-9. PubMed ID: 2265249
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant rodenticides.
Watt BE; Proudfoot AT; Bradberry SM; Vale JA
Toxicol Rev; 2005; 24(4):259-69. PubMed ID: 16499407
[TBL] [Abstract][Full Text] [Related]
20. Case management and plasma half-life in a case of brodifacoum poisoning.
Hollinger BR; Pastoor TP
Arch Intern Med; 1993 Aug; 153(16):1925-8. PubMed ID: 8250654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
